Target Price | JPY5,151.00 |
Price | JPY4,366.00 |
Potential |
17.98%
register free of charge
|
Number of Estimates | 17 |
17 Analysts have issued a price target Takeda Pharmaceutical 2026 .
The average Takeda Pharmaceutical target price is JPY5,151.00.
This is
17.98%
register free of charge
JPY6,090.00
39.49%
register free of charge
JPY4,545.00
4.10%
register free of charge
|
|
A rating was issued by 21 analysts: 12 Analysts recommend Takeda Pharmaceutical to buy, 9 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Takeda Pharmaceutical stock has an average upside potential 2026 of
17.98%
register free of charge
|
Mar '25 |
2026 Estimates |
|
---|---|---|
Revenue Billion JPY | 4,581.55 | 4,627.66 |
7.45% | 1.01% | |
EBITDA Margin | 21.52% | 26.40% |
3.66% | 22.69% | |
Net Margin | 2.36% | 5.04% |
30.28% | 113.95% |
19 Analysts have issued a sales forecast Takeda Pharmaceutical 2026 . The average Takeda Pharmaceutical sales estimate is
This results in the following potential growth metrics:
16 Analysts have issued an Takeda Pharmaceutical EBITDA forecast 2026. The average Takeda Pharmaceutical EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
20 Takeda Pharmaceutical Analysts have issued a net profit forecast 2026. The average Takeda Pharmaceutical net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Mar '25 |
2026 Estimates |
|
---|---|---|
Earnings Per Share JPY | 68.35 | 148.22 |
25.78% | 116.85% | |
P/E | 29.46 | |
EV/Sales | 2.38 |
20 Analysts have issued a Takeda Pharmaceutical forecast for earnings per share. The average Takeda Pharmaceutical EPS is
This results in the following potential growth metrics and future valuations:
Takeda Pharmaceutical...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.